Nykredit A S Invests $32.72 Million in Danaher Corporation $DHR

Key Points

• Nykredit A/S acquired 171,773 Danaher shares during the second quarter, valued at approximately $32.72 million. Institutional investors collectively own 79.05% of Danaher’s stock.
• Analysts maintain a generally positive outlook, with Danaher receiving a consensus “Moderate Buy” rating and an average price target of $228.91, despite several recent target-price reductions.
• Danaher exceeded quarterly expectations, reporting $1.94 in earnings per share versus the $1.85 estimate and $6.26 billion in revenue, up 5.5% year over year.

Nykredit A S bought a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 171,773 shares of the conglomerate's stock, valued at approximately $32,719,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Main Street Group LTD bought a new stake in Danaher during the 1st quarter valued at approximately $25,000. N.E.W. Advisory Services LLC purchased a new position in shares of Danaher in the 2nd quarter valued at approximately $25,000. JPL Wealth Management LLC purchased a new position in shares of Danaher in the 3rd quarter valued at approximately $25,000. WFA of San Diego LLC bought a new stake in shares of Danaher during the second quarter valued at approximately $26,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in Danaher in the fourth quarter worth $27,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on DHR shares. TD Cowen decreased their price objective on Danaher from $240.00 to $236.00 and set a "buy" rating for the company in a report on Wednesday, July 22nd. Wolfe Research downgraded shares of Danaher from an "outperform" rating to a "peer perform" rating in a research report on Monday, June 1st. Weiss Ratings upgraded shares of Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Wednesday, July 15th. Guggenheim lowered their price target on shares of Danaher from $235.00 to $200.00 and set a "buy" rating for the company in a research report on Wednesday, July 22nd. Finally, Royal Bank Of Canada boosted their price objective on shares of Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Danaher presently has an average rating of "Moderate Buy" and a consensus target price of $228.91.

Danaher Stock Up 0.4%

Shares of Danaher stock opened at $210.69 on Friday. The company has a 50-day simple moving average of $201.50 and a two-hundred day simple moving average of $192.17. The stock has a market capitalization of $148.11 billion, a PE ratio of 37.42, a price-to-earnings-growth ratio of 2.61 and a beta of 0.78. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analysts' expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business's revenue for the quarter was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.77 earnings per share. On average, analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source